Progyny, Inc. (NASDAQ:PGNY) Q3 2023 Earnings Call Transcript

We said that any reductions that were going to happen, even if we didn’t know about them, would be offset or more than offset by growth in organic lives. And that’s what’s been materializing for us so far this year. So I think you’re thinking about it the right way.

David Larsen: Okay, great. Thanks very much. Just one last quick one. Quantum Health, why did you select them and not, say, accolade, for example?

Pete Anevski: We have a lot of alignment with how Quantum thinks about the market and how they go about their value prop and their approach. We had a significant number of mutual clients already aligned. And so that’s always positive. But then, more broadly in general, for us, it’s having the right partners and continuing to have more channels and avenues for employers to acquire and add the fertility benefit. That’s really what is most important to us. And we’ll continue to sort of evaluate that as we continue to look at our partnerships going forward.

David Larsen: Thanks a lot. I’ll hop back into the queue. Thank you.

Operator: Thank you. That concludes the Q&A portion of the call. I will now hand the conference back to James Hart for closing remarks. Please go ahead.

James Hart: Thank you. Thank you, everyone, for joining us this afternoon. Please feel free to reach out at any time for any follow-ups that you have. Hopefully, you all know how to contact me. Otherwise, just write to investors@progyny.com Thanks so much. We look forward to speaking with you in the coming year.